Iovance Biotherapeutics is seeking a Director of HTA, Evidence, and Global Access to enhance their market access strategies for innovative cancer therapies. The role requires extensive experience in health technology assessment and a strong background in oncology, along with project management skills to support global market access activities.
Base: $240,000 - $265,000 USD annually; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified